The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Moleculin Biotech, Inc. - Clinical Stage Drug Development Company Discusses Recent News and Growth Drivers

SNNLive spoke with Walter Klemp, Chairman and CEO of Moleculin Biotech, Inc. (NASDAQ: MBRX) at the LD Micro "Main Event" 2017 in Bel Air, CA.

Share With

Tuesday, December 19, 2017

   

© 2018 Stock News Now